Tristar Pharmaceuticals Private Limited, a active private limited company, was established on 09 June 1999 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232CH1999PTC022664. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.20 Cr and a paid-up capital of ₹1.20 Cr.
It upholds a compliant status. Its leadership includes Kamlesh Agarwal (Director), Sumit Aggarwal (Managing Director), Harinder Kumar Aggarwal (Director). Past directors included Harinder Kumar Aggarwal. It holds no open charges and ₹1.26 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 181/13, Industrial Area, Phase - 1,, Chandigarh, Chandigarh, 160001.
U24232CH1999PTC022664
022664
09 June 1999
₹1.20 Cr
₹1.20 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Tristar Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamlesh Agarwal | Director | 09 Jun 1999 | Current |
| Sumit Aggarwal | Managing Director | 09 Jun 1999 | Current |
| Harinder Kumar Aggarwal | Director | 08 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Tristar Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 6.9% decrease. The company also saw a substantial fall in profitability, with a 326.22% decrease in profit. The company's net worth dipped by a decrease of 6.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Tristar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹12,576,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Apr 2007 | Canara Bank | ₹2.50 M | Satisfied |
| 06 Oct 2004 | Canara Bank | ₹0.37 M | Satisfied |
| 10 Jan 2004 | Canara Bank | ₹0.34 M | Satisfied |
| 06 Jan 2004 | Canara Bank | ₹0.37 M | Satisfied |
| 21 Apr 2003 | Canara Bank | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Tristar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Tristar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tristar Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Tristar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Tristar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was completed.
Harinder Kumar Aggarwal was appointed as a Director was appointed as a Director on 08 Sep 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.
Progress on A charge registered on 17 Apr 2007 via Charge ID 10048985 with Canara Bank was fully satisfied on 10 Feb 2010. was documented.
The activity A charge registered on 06 Oct 2004 via Charge ID 90174418 with Canara Bank was fully satisfied on 10 Feb 2010. was completed.
A charge registered on 10 Jan 2004 via Charge ID 90175493 with Canara Bank was fully satisfied on 10 Feb 2010. was recorded as a recent event.
The CIN of Tristar Pharmaceuticals Private Limited is U24232CH1999PTC022664.
Tristar Pharmaceuticals Private Limited is headquartered at Plot No. 181/13, Industrial Area, Phase - 1,, Chandigarh, Chandigarh, 160001.
Tristar Pharmaceuticals Private Limited was incorporated on 09 June 1999.
The current directors of Tristar Pharmaceuticals Private Limited are
The primary industry of Tristar Pharmaceuticals Private Limited is Manufacturing.
Tristar Pharmaceuticals Private Limited is unlisted.
The authorized capital of Tristar Pharmaceuticals Private Limited is ₹1.20 Cr, and the paid-up capital is ₹1.20 Cr.
The compliance status of Tristar Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX